2834 – Page 104 – China Stock Advice

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[______________ FORM 8-K ______________ CURRENT REPORT Date of Report (Date of earliest event reported): December 14, 2012 ______________ BIOSTAR PHARMACEUTICALS, INC. ______________ Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last]

By info| 2016-03-03T11:31:48+00:00 December 20th, 2012|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 2012-12-20, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[______________ FORM 8-K ______________ CURRENT REPORTte of Report (Date of earliest event reported):December 14, 2012 ______________ BIOSTAR PHARMACEUTICALS, ______________ Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer oforporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province Peoples Republic of China 712046 86-029-33686638 N/A (Former name or formerdress, if changed since last]

By info| 2016-02-07T15:32:30+00:00 December 20th, 2012|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 2012-12-20, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

TPI [TIANYIN PHARMACEUTICAL] POS AM: Post Effective Amendment No.4 to FORM S-1 REGISTRATION

[Post Effective Amendment No.4 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) 20-4857782 (I.R.S. Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 Renmin Road South, Chengdu, P. R. China, 610041 +0086-28-86154737 Dr. Guoqing Jiang Chief Executive Officer Tianyin Pharmaceutical Co.,] [HUNTER TAUBMAN WEISS LLP 17 State Street, Suite 2000 New York, New York 10007 (212) 732-7184 Fax: (212) 202-6380 E-mail: LTaubman@htwlaw.com December 7, 2012 Tianyin Pharmaceutical Co., Inc. 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 Ladies and Gentlemen: In so acting, we have examined and relied upon the originals or] [Patrizio & Zhao, LLC Certified Public Accountants and Consultants 322 Route 46 West Parsippany, NJ 07054 Fax: (973) 882-0788 www.pzcpa.com Member of Alliance of worldwide accounting firms CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the use in the Post-Effective Amendment No. 4 to a Registration Statement on Form S-1 pertaining to the registration of 15,784,640 shares of]

By info| 2016-03-27T18:55:22+00:00 December 7th, 2012|Categories: Chinese Stocks, TPI, Webplus ver|Tags: 0001362718, 2012-12-07, 2834, PHARMACEUTICAL PREPARATIONS, POS_AM, TPI|0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)

[TPI Reports First Quarter Fiscal Year 2013 Financial Results CHENGDU, China, Nov. 15, 2012 -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for first quarter of the fiscal year 2013. First Quarter of Fiscal Year 2013 Ended] [Tianyin Pharmaceutical Co., Inc. (“TPI”) First Quarter of Fiscal Year 2013 Earnings Call November 15, 2012 8:30 AM ET Operator James Tong TPI First quarter of fiscal year 2013 ended September 30, 2012, financial highlights: revenue was $16 million compared with $17.5 million in first quarter of fiscal year 2012 (“FIQ 2012”). Operating income was $2.2 million compared with $2.1] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT November 15, 2012 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]

By info| 2016-03-27T18:56:42+00:00 November 23rd, 2012|Categories: Chinese Stocks, SEC Original, TPI|Tags: 0001362718, 2012-11-23, 2834, 8-K, PHARMACEUTICAL PREPARATIONS, TPI|0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: TPI Reports First Quarter Fiscal Year 2013 Financial

[TPI Reports First Quarter Fiscal Year 2013 Financial Results CHENGDU, China, Nov. 15, 2012 -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for first quarter of the fiscal year 2013. First Quarter of Fiscal Year 2013 Ended] [Tianyin Pharmaceutical Co., Inc. (“TPI”) First Quarter of Fiscal Year 2013 Earnings Call November 15, 2012 8:30 AM ET Operator James Tong TPI First quarter of fiscal year 2013 ended September 30, 2012, financial highlights: revenue was $16 million compared with $17.5 million in first quarter of fiscal year 2012 (“FIQ 2012”). Operating income was $2.2 million compared with $2.1] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT November 15, 2012 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]

By info| 2016-03-27T18:58:35+00:00 November 23rd, 2012|Categories: Chinese Stocks, TPI, Webplus ver|Tags: 0001362718, 2012-11-23, 2834, 8-K, PHARMACEUTICAL PREPARATIONS, TPI|0 Comments

BSPM [Biostar Pharmaceuticals,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x September 30, 2012 For the quarterly period ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Zack Pan, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ronghua Wang Chief Executive Officer EX-32.1 4 ex32-1.htm] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Zack Pan Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm]

By info| 2016-03-03T11:36:08+00:00 November 19th, 2012|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 10-Q, 2012-11-19, 2834, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

BSPM [Biostar Pharmaceuticals,] 10-Q: FORM 10-Q (Mark One) x September 30, 2012

[FORM 10-Q (Mark One) x September 30, 2012 For the quarterly period ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Zack Pan, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ronghua Wang Chief Executive Officer EX-32.1 4 ex32-1.htm] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Zack Pan Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm]

By info| 2016-03-03T11:37:58+00:00 November 19th, 2012|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 10-Q, 2012-11-19, 2834, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMAS,] DEF 14A: (Original Filing)

[SCHEDULE 14A INFORMATION þ o Check the appropriate box: o Preliminary Proxy Statement o þ Definitive Proxy Statement o Definitive Additional Materials o CHINA PHARMA HOLDINGS, INC . Payment of Filing Fee (Check the appropriate box): þ No fee required. o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.]

By info| 2016-03-03T17:32:41+00:00 November 19th, 2012|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 2012-11-19, 2834, CPHI, DEF_14A, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMAS,] DEF 14A: SCHEDULE 14A INFORMATION þ o Check the appropriate

[SCHEDULE 14A INFORMATION þ o Check the appropriate box: o Preliminary Proxy Statement o þ Definitive Proxy Statement o Definitive Additional Materials o CHINA PHARMA HOLDINGS, INC . Payment of Filing Fee (Check the appropriate box): þ No fee required. o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.]

By info| 2016-03-03T17:34:21+00:00 November 19th, 2012|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 2012-11-19, 2834, CPHI, DEF_14A, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMAS,] DEF 14A: SCHEDULE 14A INFORMATION o Check the appropriate box:

[SCHEDULE 14A INFORMATION o Check the appropriate box: o Preliminary Proxy Statement o Definitive Proxy Statement o Definitiveditional Materials o CHINA PHARMAS, . Payment of Filing Fee (Check the appropriate box): No fee required. o Feemputed on table below per Exchange Act Rules14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction]

By info| 2016-02-07T21:52:28+00:00 November 19th, 2012|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 2012-11-19, 2834, CPHI, DEF_14A, PHARMACEUTICAL PREPARATIONS|0 Comments